36 completed. 36 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 36 | Completed 36 |
| Phase 1 | 3 | Completed 3 |
Follow CT: new trials by email Literature Review of CT trials Research Report on CT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma Computed Tomography, Electronic Health Record Review, Ga-68 PSMA-11 - Metastatic Adenoid Cystic Carcinoma | Phase 2 | Completed | Mayo Clinic | 6 | 2024-08-12 | 2025-09-12 |
| Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer Biopsy, Biospecimen Collection, Computed Tomography - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Completed | Mayo Clinic | 7 | 2024-03-08 | 2026-06-09 |
| 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 | Phase 2 | Completed | Mayo Clinic | 26 | 2022-01-30 | 2026-09-29 |
| Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Ibrutinib, ECG, PFT's - Chronic GVHD | Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2021-05-10 | 2026-01-23 |
| 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Magnetic Resonance Imaging - Hepatocellular Carcinoma | Phase 2 | Completed | Mayo Clinic | 52 | 2021-02-24 | 2026-08-12 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma Atezolizumab, Biopsy, Biospecimen Collection - Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 47 | 2019-06-05 | 2024-07-26 |
| Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery Computed Tomography, Fluciclovine F18, Gallium Ga 68-labeled PSMA-11 - Recurrent Prostate Carcinoma | Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 50 | 2019-04-12 | 2020-10-14 |
| 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy Computed Tomography, Fluorodopa F 18, Magnetic Resonance Imaging - Glioblastoma, Malignant Glioma | Phase 2 | Completed | Mayo Clinic | 43 | 2019-03-28 | 2025-07-03 |
| 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Cigarette Smoker, Current Smoker | Phase 2 | Completed | Andrei Iagaru | 15 | 2019-02-04 | 2025-04-09 |
| Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone | Phase 2 | Completed | University of Utah | 17 | 2018-10-02 | 2024-11-29 |
| 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer Computed Tomography, Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography - Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 937 | 2018-04-02 | 2021-09-30 |
| Fatigue Interventions in Cancer (Exercise Intervention) Cognitive Behavior Therapy, Exercise Intervention - Sedentary Lifestyle, Stage III Prostate Cancer AJCC v7 | Phase 2 | Completed | University of Utah | 126 | 2018-02-26 | 2026-02-17 |
| Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer Atezolizumab, Biopsy, Biospecimen Collection - Gallbladder Carcinoma, Metastatic Cholangiocarcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 86 | 2018-02-08 | 2024-04-05 |
| Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) Biospecimen Collection, Computed Tomography, FDG-Positron Emission Tomography - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 18 | 2017-11-28 | 2026-04-21 |
| TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer Anastrozole, Denifanstat, Exemestane - Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma | Phase 2 | Completed | Mayo Clinic | 17 | 2017-08-03 | 2026-10-09 |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Cirrhosis, Hepatocellular Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 52 | 2017-06-21 | 2026-09-09 |
| 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer Computed Tomography, Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Laboratory Biomarker Analysis - Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma | Phase 2 | Completed | Andrei Iagaru | 44 | 2017-04-10 | 2023-12-12 |
| Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Azacitidine, Biospecimen Collection, Computed Tomography - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Completed | National Cancer Institute (NCI) | 78 | 2017-04-01 | 2025-02-27 |
| [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer 18F-Fluoromisonidazole, Arterial Embolization, Computed Tomography - Adult Liver Carcinoma, Liver Cirrhosis | Phase 2 | Completed | Stanford University | 5 | 2016-09-13 | 2024-01-31 |
| Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed Biospecimen Collection, Bone Scan, Cabozantinib S-malate - Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 152 | 2016-07-25 | 2025-01-13 |
Showing 20 of 36. Sign in to see all of them.
Prostatic Neoplasms (7) · Carcinoma, Hepatocellular (5) · Breast Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (3) · Burkitt Lymphoma (2) · Glioma (2) · Hematologic Neoplasms (2) · Lymphoma, Non-Hodgkin (2) · Stomach Neoplasms (2) · Biliary Tract Neoplasms (1) · Brain Neoplasms (1) · Bronchiolitis Obliterans Syndrome (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1)
National Cancer Institute (NCI) (16) · Mayo Clinic (7) · Andrei Iagaru (2) · Jonsson Comprehensive Cancer Center (2) · Stanford University (2) · University of Utah (2) · Albert Einstein College of Medicine (1) · Queen's Medical Center (1) · SOLTI Breast Cancer Research Group (1) · University of Washington (1) · Vanderbilt-Ingram Cancer Center (1)
United States (35) · Canada (4) · Puerto Rico (3) · Australia (1) · Spain (1)
Andrei Iagaru (2) · Ajit H. Goenka, M.D. (1) · Antoni Ribas (1) · Brian J. Burkett, MD, MPH (1) · Carina Mari Aparici (1) · Chirayu Shah, MD (1) · Christopher J Melani, M.D. (1) · Deborah E Citrin, M.D. (1) · Eva Ciruelos, MD (1) · Evan Y Yu (1) · Harry H. Yoon, M.D. (1) · Jacob Orme, M.D., Ph.D. (1) · Jeffrey Yap, PhD (1) · Jeremie Calais (1)
PMID 23574119, PMID 24224624, PMID 25024303, PMID 26359256, PMID 26659347, PMID 29315063, PMID 29748435, PMID 30125215, PMID 31142507, PMID 31375469, PMID 31401903, PMID 33027064, PMID 33084020, PMID 33369581, PMID 33592176, PMID 33602654, PMID 34172602, PMID 34432874, PMID 34783177, PMID 34907910, PMID 35485937, PMID 35882475, PMID 37011643, PMID 37146227, PMID 37555901, PMID 38261444, PMID 38867582, PMID 38981590, PMID 39255440, PMID 39365957, PMID 39571596, PMID 41698328
P30CA124435 (2), U10CA180886 (2), U10CA180888 (2), 2014 (1), N01CM00032 (1), N01CM00038 (1), N01CM00039 (1), N01CM00070 (1), N01CM00071 (1), N01CM00099 (1), N01CM27165 (1), N01CM62201 (1), N01CM62202 (1), N01CM62203 (1), N01CM62209 (1)